Fact CheckerSign in

NCT06663826Completed

Development of Digital Diagnostic Devices for Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 9 Sept 2026

Brief summary (registry, in English)

In this project, ocular motor, pupil and gait data in people with Parkinson's disease (PD) will be collected in order to develop machine learning models for the diagnosis and monitoring of PD. With this, the investigators aim to advance the state of the art in PD diagnosis and monitoring. By integrating the principles of machine learning with high-quality sensor data, more accurate and earlier diagnosis could potentially be achieved. Ocular motor and pupil data will be collected with the standard clinical examination and with neos, a medical device approved for objective ocular motor and pupil measurement. Gait will be collected using an IMU sensor and GaitQ senti, a consumer device that allows for an objective and continuous remote gait monitoring.

Status (registry)
Completed
Study type
Observational
Enrollment
116 (actual)
First submitted
24 Oct 2024
Start date
1 Oct 2024
Primary completion date
30 Nov 2025
Lead sponsor
machineMD AG
NCT number
NCT06663826

What you commit to

  • Study type: Observational
  • Participants enrolled: 116
  • From 1 Oct 2024 to the primary completion date, 30 Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current medication/drugs that could potentially influence performance in ocular motor tasks and/or compliance in the judgement of the investigator (e.g. benzodiazepines, alcohol, stimulants, or recreational drugs) - except Parkinson's medications

Other illness

  • Other known neurological diseases
  • Incapacity to understand and comply with the examination (e.g. due to advanced cognitive decline, failure to comply with easy experimental instructions and tasks)
  • Any injury or disorder that may affect eye movement measurements or balance (other than Parkinson's or referring primary condition)
  • Any skin conditions or broken skin in the calf and behind the knee area

Other

  • Lack of access or limited connectivity to WiFi in home setting

Who the study is looking for

  • Diagnosis of Parkinson's disease or of another parkinsonian syndrome (atypical Parkinson's)
  • Refractive error between -6 and +4 diopters, on both eyes
  • Informed consent by participant documented per signature
  • Able to self-report history of daily gait freezing and/or festination
  • Able to walk unsupported or using an aid for at least 5 minutes and if over 69 used to carrying out this level of exercise

Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital of Zurich
Coordinator of this site? Confirm its status
ZurichSwitzerlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.